Viewing Study NCT03113695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-02-20 @ 6:04 PM
Study NCT ID: NCT03113695
Status: COMPLETED
Last Update Posted: 2022-07-05
First Post: 2017-04-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome
Sponsor: University of California, San Diego
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Richter's Syndrome View
None CLL View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Richter's Syndrome View
None CLL View
None Chronic Lumphocytic Leukemia View
None obinutuzumab View
None HDMP View
None lenalidomide View
None cancer View
None methylprednisolone View